Efficacy and Safety of Glycogen Synthase Kinase 3 Inhibitors for Alzheimer's Disease: A Systematic Review and Meta-Analysis.

Matsunaga, Shinji; Fujishiro, Hiroshige; Takechi, Hajime

Matsunaga, Shinji; Fujishiro, Hiroshige; Takechi, Hajime.

Afiliação

Matsunaga S; Department of Geriatrics and Cognitive Disorders, Fujita Health University School of Medicine, Kutsukake, Toyoake, Aichi, Japan.
Fujishiro H; Department of Psychiatry, Kawasaki Memorial Hospital, Miyamae, Kawasaki, Kanagawa, Japan.
Takechi H; Department of Geriatrics and Cognitive Disorders, Fujita Health University School of Medicine, Kutsukake, Toyoake, Aichi, Japan.

J Alzheimers Dis ; 69(4): 1031-1039, 2019.

Article em En | MEDLINE | ID: mdl-31156177

Assuntos

Doença de Alzheimer/tratamento farmacológico; Quinase 3 da Glicogênio Sintase/antagonistas & inibidores; Nootrópicos/uso terapêutico; Humanos; Nootrópicos/efeitos adversos

Palavras-chave

Alzheimer's disease; glycogen synthase kinase 3; lithium; meta-analysis; tideglusib

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Nootrópicos / Quinase 3 da Glicogênio Sintase / Doença de Alzheimer Tipo de estudo: Clinical_trials / Systematic_reviews Limite: Humans Idioma: En Revista: J Alzheimers Dis Ano de publicação: 2019 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google